C
GYRE icon

Covestor’s Gyre Therapeutics GYRE Stock Holding History

Covestor’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
48
+34
+243% +$232 ﹤0.01% 2627
2026
Q1 		$0 Buy
14
+8
+133% +$62 ﹤0.01% 2466
2025
Q4 		$0 Hold
6
– – ﹤0.01% 2445
2025
Q3 		$0 Hold
6
– – ﹤0.01% 2468
2025
Q2 		$0 Sell
6
-1
-14% -$9 ﹤0.01% 2421
2025
Q1 		$0 Hold
7
– – ﹤0.01% 2426
2024
Q4 		$0 Buy
7
+1
+17% +$13 ﹤0.01% 2436
2024
Q3 		$0 Buy
+6
New +$77 ﹤0.01% 2420

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Covestor's GYRE Position: Q2 2026 in Review

Covestor increased its Gyre Therapeutics (GYRE) stake by 243% in Q2 2026, buying an estimated $232 and bringing the position to 48 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

Covestor first reported a position in GYRE in Q3 2024 and has held it in 8 quarters since. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Covestor held 48 shares of Gyre Therapeutics worth $0 as of Q2 2026.
  • Covestor bought 34 Gyre Therapeutics shares in Q2 2026, an estimated $232.
  • Gyre Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2627 holding.
  • Covestor first reported a position in Gyre Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.